World's Best Scientists 2026 revealed!
Anthony K.C. Chan

Anthony K.C. Chan

D-Index & Metrics

Medicine

D-Index
80
Citations
24342
World Ranking
17077
National Ranking
718

Anthony K.C. Chan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony K.C. Chan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony K.C. Chan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony K.C. Chan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His primary areas of investigation include Pediatrics, Surgery, Internal medicine, Low molecular weight heparin and Thrombosis. The study incorporates disciplines such as Odds ratio, Epidemiology, Cohort study, Stroke and Cohort in addition to Pediatrics. The Surgery study combines topics in areas such as Observational study and Risk factor.

In his study, which falls under the umbrella issue of Internal medicine, Neuroendocrine tumors, Carcinoid tumors, Perforation and Radiology is strongly linked to Gastroenterology. His research on Low molecular weight heparin also deals with topics like

  • Anticoagulant that intertwine with fields like Prospective cohort study, Enoxaparin sodium, Warfarin and Heparin,
  • Inferior vena cava which is related to area like Heparin-induced thrombocytopenia. His biological study spans a wide range of topics, including Pulmonary embolism, Antithrombotic and Intensive care medicine.

His most cited work include:

  • Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (827 citations)
  • Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) (581 citations)
  • Neuroendocrine tumor epidemiology: contrasting Norway and North America. (384 citations)

What are the main themes of his work throughout his whole career to date?

Anthony K.C. Chan mainly focuses on Internal medicine, Thrombosis, Pediatrics, Heparin and Surgery. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Immunology and Cardiology. Anthony K.C. Chan works mostly in the field of Thrombosis, limiting it down to concerns involving Intensive care medicine and, occasionally, MEDLINE and Clinical trial.

His study in Pediatrics is interdisciplinary in nature, drawing from both Odds ratio, Epidemiology, Cohort study, Prospective cohort study and Risk factor. His Heparin study incorporates themes from Anticoagulant and Pharmacology. His Anticoagulant research is multidisciplinary, relying on both Anesthesia, Warfarin and Antithrombotic.

He most often published in these fields:

  • Internal medicine (32.89%)
  • Thrombosis (25.22%)
  • Pediatrics (23.68%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (32.89%)
  • Thrombosis (25.22%)
  • Pediatrics (23.68%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Thrombosis, Pediatrics, Incidence and Heparin. His Thrombosis study combines topics from a wide range of disciplines, such as Hemostasis, Rivaroxaban and Clinical trial. Anthony K.C. Chan interconnects Randomized controlled trial, Intensive care medicine, Brain ischemia, Disease and Prospective cohort study in the investigation of issues within Pediatrics.

His research in Incidence intersects with topics in Epidemiology and Cohort study. His primary area of study in Heparin is in the field of Low molecular weight heparin. His Low molecular weight heparin research integrates issues from Anticoagulant and Fondaparinux.

Between 2016 and 2021, his most popular works were:

  • American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. (87 citations)
  • Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry. (85 citations)
  • Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His primary scientific interests are in Thrombosis, Pediatrics, Internal medicine, MEDLINE and Rivaroxaban. His research integrates issues of Adverse effect, Incidence and Cohort study in his study of Thrombosis. His studies deal with areas such as Randomized controlled trial, Brain ischemia, Disease, Evidence-based medicine and Low molecular weight heparin as well as Pediatrics.

Anthony K.C. Chan frequently studies issues relating to Surgery and Internal medicine. He has researched Surgery in several fields, including Gastroenterology and National Health and Nutrition Examination Survey. His work in MEDLINE tackles topics such as Intensive care medicine which are related to areas like Venous thromboembolism.

Best Publications

  • Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Paul Monagle;Anthony K. C. Chan;Neil A. Goldenberg;Rebecca N. Ichord

  • Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

    Paul Monagle;Elizabeth Chalmers;Anthony Chan;Gabrielle deVeber

  • Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

    Paul Monagle;Anthony Chan;Patti Massicotte;Elizabeth Chalmers

  • Neuroendocrine tumor epidemiology: contrasting Norway and North America.

    Oyvind Hauso;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Helge L. Waldum

  • Bronchopulmonary neuroendocrine tumors

    Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Anthony Chan;Max V. Malfertheiner

  • Developmental haemostasis : Impact for clinical haemostasis laboratories

    Paul Monagle;Chris Barnes;Vera Ignjatovic;Janine Furmedge

  • Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.

    Scott Kaatz;Peter A. Kouides;David A. Garcia;Alex C. Spyropolous

  • Chickenpox and Stroke in Childhood A Study of Frequency and Causation

    Rand Askalan;Suzanne Laughlin;Supriya Mayank;Anthony Chan

  • Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children A Systematic Review and Meta-Analysis of Observational Studies

    Gili Kenet;Lisa K. Lütkhoff;Manuela Albisetti;Timothy Bernard

  • American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.

    Paul Monagle;Carlos A. Cuello;Carlos A. Cuello;Caitlin Augustine;Mariana Bonduel

  • Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry.

    Gabrielle A. deVeber;Adam Kirton;Frances A. Booth;Jerome Y. Yager

  • Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology

    Geoffrey C. Nguyen;Geoffrey C. Nguyen;Charles N. Bernstein;Alain Bitton;Anthony K. Chan

  • Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients

    W. Streif;W. Streif;M. Andrew;M. Andrew;V. Marzinotto;V. Marzinotto;P. Massicotte;P. Massicotte

  • The use of low molecular weight heparin in pediatric patients: a prospective cohort study.

    David Dix;Maureen Andrew;Velma Marzinotto;Karen Charpentier

  • Impact of Inherited Thrombophilia on Venous Thromboembolism in Children A Systematic Review and Meta-Analysis of Observational Studies

    Guy Young;Manuela Albisetti;Mariana Bonduel;Leonardo Brandao

  • Prothrombotic disorders in infants and children with cerebral thromboembolism

    Gabrielle deVeber;Paul Monagle;Anthony Chan;Daune MacGregor

  • Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

    Christoph Male;Anthonie W A Lensing;Joseph S Palumbo;Joseph S Palumbo;Riten Kumar

  • Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.

    Mark A. Crowther;Leslie R. Berry;Paul T. Monagle;Anthony K. C. Chan

  • Anticoagulants in pediatric cerebral sinovenous thrombosis: A safety and outcome study

    Mahendranath D. Moharir;Manohar Shroff;Derek Stephens;Ann-Marie Pontigon

  • An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

    Patricia Massicotte;Jim A Julian;Michael Gent;Karen Shields

Frequent Co-Authors

Maureen Andrew
Maureen Andrew University of Toronto
Gabrielle deVeber
Gabrielle deVeber University of Toronto
Brian W. McCrindle
Brian W. McCrindle University of Toronto
Adam Kirton
Adam Kirton University of Calgary
Lehana Thabane
Lehana Thabane McMaster University
John L. Brash
John L. Brash McMaster University
Marilyn J. Manco-Johnson
Marilyn J. Manco-Johnson University of Colorado Anschutz Medical Campus
Fenella J. Kirkham
Fenella J. Kirkham University College London
Mark Crowther
Mark Crowther McMaster University
Jim A. Julian
Jim A. Julian McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA now offers more flexibility than ever with a variety of online degree options. For those interested in the administrative side of healthcare, an accelerated healthcare administration degree online can help you quickly move into roles such as hospital management or clinic coordination.

Nursing professionals seeking to advance their clinical expertise may choose an adn to np bridge program, allowing them to progress from an Associate Degree in Nursing to becoming a Nurse Practitioner with a Master’s degree.

Nutrition is a growing area within healthcare, and earning online degrees in nutrition enables students to focus on dietetics, wellness, and chronic disease prevention through flexible study options.

For those aiming for leadership or specialized roles, cahme-accredited online mha programs provide the advanced business, policy, and management education needed to succeed in today’s competitive healthcare landscape.

These diverse online programs cater to various interests within medicine and healthcare, opening doors to impactful and rewarding career pathways beyond traditional medical degrees.

Best Scientists Citing Anthony K.C. Chan

Trending Scientists

Recently Published Articles